Resultados de búsqueda - Papadopoulos, Kyriakos

Temperature and Salting out Effects on Nicotine Dissolution Kinetics in Saline Solutions por Chen, Chia-Yu, Papadopoulos, Kyriakos D.

Enlace del recurso Enlace del recurso Enlace del recurso

trans-Double Bond-Containing Liposomes as Potential Carriers for Drug Delivery por Giacometti, Giorgia, Marini, Marina, Papadopoulos, Kyriakos, Ferreri, Carla, Chatgilialoglu, Chryssostomos

Enlace del recurso Enlace del recurso Enlace del recurso

Temperature-Induced Protein Release from Water-in-Oil-in-Water Double Emulsions por Rojas, Edith C., Staton, Jennifer A., John, Vijay T., Papadopoulos, Kyriakos D.

Enlace del recurso Enlace del recurso Enlace del recurso

Liposomes in Double-Emulsion Globules por Wang, Qing, Tan, Grace, Lawson, Louise B., John, Vijay T., Papadopoulos, Kyriakos D.

Enlace del recurso Enlace del recurso Enlace del recurso

Anti‐Hu‐Associated Autoimmune Limbic Encephalitis in a Patient with PD‐1 Inhibitor‐Responsive Myxoid Chondrosarcoma por Papadopoulos, Kyriakos P., Romero, Rebecca S., Gonzalez, Gabriela, Dix, James E., Lowy, Israel, Fury, Matthew

Enlace del recurso Enlace del recurso Enlace del recurso

Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: a phase 1 dose-escalation trial por Papadopoulos, Kyriakos P., Ben-Ami, Eytan, Patnaik, Amita, Trone, Denise, Li, Jianke, Demetri, George D.

Enlace del recurso Enlace del recurso Enlace del recurso

Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours por Tachibana, Masaya, Papadopoulos, Kyriakos P., Strickler, John H., Puzanov, Igor, Gajee, Roohi, Wang, Yibin, Zahir, Hamim

Enlace del recurso Enlace del recurso Enlace del recurso

Phase I Study of MK-4166, an Anti-Human Glucocorticoid-Induced Tumor Necrosis Factor Receptor Antibody, Alone or With Pembrolizumab in Advanced Solid Tumors por Papadopoulos, Kyriakos P., Autio, Karen, Golan, Talia, Dobrenkov, Konstantin, Chartash, Elliot, Chen, Qiusheng, Wnek, Richard, Long, Georgina V.

Enlace del recurso Enlace del recurso Enlace del recurso

Membrane Lipidome Reorganization and Accumulation of Tissue DNA Lesions in Tumor-Bearing Mice: An Exploratory Study por Krokidis, Marios G., Louka, Maria, Efthimiadou, Eleni K., Zervou, Sevasti-Kiriaki, Papadopoulos, Kyriakos, Hiskia, Anastasia, Ferreri, Carla, Chatgilialoglu, Chryssostomos

Enlace del recurso Enlace del recurso Enlace del recurso

Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors por Papadopoulos, Kyriakos P., Lakhani, Nehal, Falchook, Gerald S., Riley, Gosia, Baeck, Johan, Brown, Karen S., Gordon, Gilad, Le, Lidya, Wang, Judy S.

Enlace del recurso Enlace del recurso Enlace del recurso

Assessment of DNA Topoisomerase I Unwinding Activity, Radical Scavenging Capacity, and Inhibition of Breast Cancer Cell Viability of N-alkyl-acridones and N,N′-dialkyl-9,9′-biacrid... por Krokidis, Marios G., Molphy, Zara, Efthimiadou, Eleni K., Kokoli, Marianna, Argyri, Smaragda-Maria, Dousi, Irini, Masi, Annalisa, Papadopoulos, Kyriakos, Kellett, Andrew, Chatgilialoglu, Chryssostomos

Enlace del recurso Enlace del recurso Enlace del recurso

A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors por Smith, David C., Chugh, Rashmi, Patnaik, Amita, Papadopoulos, Kyriakos P., Wang, Min, Kapoun, Ann M., Xu, Lu, Dupont, Jakob, Stagg, Robert J., Tolcher, Anthony

Enlace del recurso Enlace del recurso Enlace del recurso

Physiologically‐based pharmacokinetic modelling to predict oprozomib CYP3A drug–drug interaction potential in patients with advanced malignancies por Ou, Ying, Xu, Yang, Gore, Lia, Harvey, R. Donald, Mita, Alain, Papadopoulos, Kyriakos P., Wang, Zhengping, Cutler, Richard E., Pinchasik, Dawn E., Tsimberidou, Apostolia M.

Enlace del recurso Enlace del recurso Enlace del recurso

Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with... por Naing, Aung, Eder, Joseph P, Piha-Paul, Sarina A, Gimmi, Claude, Hussey, Elizabeth, Zhang, Sen, Hildebrand, Vera, Hosagrahara, Vinayak, Habermehl, Christina, Moisan, Jacques, Papadopoulos, Kyriakos P

Enlace del recurso Enlace del recurso Enlace del recurso

Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis por Paccaly, Anne J., Migden, Michael R., Papadopoulos, Kyriakos P., Yang, Feng, Davis, John D., Rippley, Ronda K., Lowy, Israel, Fury, Matthew G., Stankevich, Elizabeth, Rischin, Danny

Enlace del recurso Enlace del recurso Enlace del recurso

Pegilodecakin as monotherapy or in combination with anti‐PD‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohor... por Tannir, Nizar M., Papadopoulos, Kyriakos P., Wong, Deborah J., Aljumaily, Raid, Hung, Annie, Afable, Manuel, Kim, Jong Seok, Ferry, David, Drakaki, Alexandra, Bendell, Johanna, Naing, Aung

Enlace del recurso Enlace del recurso Enlace del recurso

First‐in‐Human Phase I Study of Envafolimab, a Novel Subcutaneous Single‐Domain Anti‐PD‐L1 Antibody, in Patients with Advanced Solid Tumors por Papadopoulos, Kyriakos P., Harb, Wael, Peer, Cody J., Hua, Qiong, Xu, Siying, Lu, Haolan, Lu, Ni, He, Yue, Xu, Ting, Dong, Ruiping, Gong, John, Liu, David

Enlace del recurso Enlace del recurso Enlace del recurso

Phase I Dose-Escalation Study of EZN-2208 (PEG-SN38), a Novel Conjugate of Poly(ethylene) Glycol and SN38, Administered Weekly in Patients With Advanced Cancer por Patnaik, Amita, Papadopoulos, Kyriakos P., Tolcher, Anthony W., Beeram, Muralidhar, Urien, Saïk, Schaaf, Larry J., Tahiri, Sanaa, Bekaii-Saab, Tanios, Lokiec, François M., Rezaï, Keyvan, Buchbinder, Aby

Enlace del recurso Enlace del recurso Enlace del recurso

A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors por Papadopoulos, Kyriakos P., Burris, Howard A., Gordon, Michael, Lee, Peter, Sausville, Edward A., Rosen, Peter J., Patnaik, Amita, Cutler, Richard E., Wang, Zhengping, Lee, Susan, Jones, Suzanne F., Infante, Jeffery R.

Enlace del recurso Enlace del recurso Enlace del recurso

Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer por Goldman, Jonathan W., Rosen, Lee S., Tolcher, Anthony W., Papadopoulos, Kyriakos, Beeram, Muralidhar, Shi, Peipei, Pitou, Celine, Bell, Robert, Kulanthaivel, Palaniappan, Zhang, Xuekui, Fink, Aaron, Chan, Edward M., Shahir, Ashwin, Farrington, Daphne, Patnaik, Amita

Enlace del recurso Enlace del recurso Enlace del recurso